hiddem gem in cannabis market (NUMI)

[daisyfresh]

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders
V.NUMI | 4 hours ago

https://stockhouse.com/news/press-releases/2020/11/18/numinus-announces-compassionate-access-trial-of-psilocybin-assisted

VANCOUVER, BC , Nov. 18, 2020 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI ), a company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies, has announced it will undertake a compassionate access clinical trial of psilocybin-assisted psychotherapy for substance use disorders. This study will enable the company to implement, test, and refine optimal protocols for the use of psilocybin-assisted psychotherapy for participants with a range of substance use disorders and will be conducted in collaboration with Syreon Corporation , a global contract research organization with expertise in conducting clinical trials across a broad range of chronic and complex diseases. The study will involve an initial 30 participants who will take part in a motivational enhancement psychedelic psychotherapy intervention with psilocybin.

[daisyfresh]

1st Canadian PubCo to “Complete Legal Harvest of Psilocybe Mushrooms”
Dave Jackson Dave Jackson, Stockhouse
0 Comments| 12 hours ago
0
+ Favourites
In a recent Stockhouse podcast, many of our investor audiences were introduced to a new Company that’s advancing psychedelic laboratory testing, therapy, and research, with an ultimate purpose of delivering the highest quality outcomes to their clients.

Today, Numinus Wellness Inc. (NUMI) (TSX-V.NUMI, OTCMKTS: LKYSF, Forum) is at the scientific forefront of developing safe, evidence-based psychedelic-assisted psychotherapies and other transformative and supportive health solutions. The Company says that it is “creating an ecosystem of health solutions” aimed at advancing psychedelic laboratory testing, therapy, and clinical research.

Also known as ‘magic mushrooms’, psilocybin and psilocybin-assisted psychotherapy are currently being studied as treatments for a wide range of mental health conditions including depression, anxiety, and substance use disorders. NUMI just made a giant leap forward for the entire psychedelic industry.

[daisyfresh]

Yes, there is movement, and much more to come?

[Cash1972]

Finally we got a movement in pps and a great one.

Next week we can surely reach a more fair valuation.

I expect a trip to 1 CAD.